Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NVS
Recent news which mentions NVS
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Novartis Elevates Midterm Sales Forecast, CEO Highlights Robust Pipeline
November 21, 2024
Tickers
NEWS
NVS
Tags
Biotech
Stories That Matter
Benzinga
From
Benzinga
Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details
November 12, 2024
Tickers
ARKG
NEWS
NVS
SDGR
Tags
Market News
NVS
SDGR
From
Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
October 30, 2024
Tickers
ABBV
AMGN
BIIB
BMY
Tags
LLY
ABBV
Trading Ideas
From
Benzinga
Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy
October 30, 2024
Tickers
BMY
GILD
LYEL
NEWS
Tags
News
AG Ashley Moody
SHL
From
Benzinga
Novartis Ag (NVS) Q3 2024 Earnings Call Transcript
October 29, 2024
Tickers
NVS
Tags
Market News
Recent Press Releases
NVS
From
Motley Fool
Novartis Q3 Earnings Beats Expectations On Strong Sales From Key Drugs, Lifts 2024 Outlook
October 29, 2024
Tickers
NEWS
NVS
Tags
Earnings
Health Care
Top Stories
From
Benzinga
Why Is Monte Rosa Therapeutics Stock Surging On Monday?
October 28, 2024
Tickers
GLUE
NEWS
NVS
Tags
why it's moving
Contracts
Market News
From
Benzinga
3 Absurdly Cheap Stocks That Pay High Dividends
October 24, 2024
Tickers
GILD
MRK
NVS
Tags
MRK
Recent Press Releases
NVS
From
Motley Fool
After US Senator, Unions Urge Federal Trade Commission To Block Novo's $16.5B Acquisition Of Catalent
October 18, 2024
Tickers
CTLT
NEWS
NVO
NVS
Tags
M&A
Market News
NVS
From
Benzinga
European Medicines Agency's Panel Supports Approval Of Novartis' Kisqali In Patients With Early-Breast Cancer
October 18, 2024
Tickers
NEWS
NVS
SNY
Tags
Health Care
SNY
Equities
From
Benzinga
1 Healthcare Giant That Isn't Jumping on the GLP-1 Bandwagon, and Why That Could Be a Great Move
October 17, 2024
Tickers
NVS
Tags
NVS
Recent Press Releases
Market News
From
Motley Fool
Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch
October 16, 2024
Tickers
ALPMF
ALPMY
APLS
NEWS
Tags
Market News
NVS
Analyst Color
From
Benzinga
Looking Into Novartis's Recent Short Interest
October 14, 2024
Tickers
NVS
Tags
Short Sellers
BZI/SHORTHIST
Market News
From
Benzinga
2 Magnificent Dividend Stocks to Buy and Hold Forever
October 14, 2024
Tickers
ABBV
NVS
Tags
Recent Press Releases
NVS
Market News
From
Motley Fool
Recently Listed Cancer Firm OnKure's Innovative Approach to Breast Cancer Treatment Sparks Analyst Enthusiasm
October 10, 2024
Tickers
NEWS
NVS
OKUR
Tags
Trading Ideas
Health Care
Top Stories
From
Benzinga
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
October 01, 2024
Tickers
AZN
LLY
NEWS
NVO
Tags
General
Benzinga
Stories That Matter
From
Benzinga
Incyte Downgraded - Analyst Notes Intense Competition, Particularly In Larger Markets
September 18, 2024
Tickers
INCY
NEWS
NVS
Tags
Health Care
INCY
Trading Ideas
From
Benzinga
Novartis' Multiple Sclerosis Drug Data Shows Most Patients Remain With No Disability Progression For Up To Six Years
September 18, 2024
Tickers
NEWS
NVS
SNY
Tags
Benzinga
Health Care
Biotech
From
Benzinga
This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday
September 11, 2024
Tickers
ACET
ANIP
NEWS
NVS
Tags
Benzinga
ACET
RLAY
From
Benzinga
Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday
September 11, 2024
Tickers
APP
ASO
ATOS
CAC
Tags
SUPN
Pre/Market Outlook
CAC
From
Benzinga
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
September 09, 2024
Tickers
AZN
BMY
ELVN
NEWS
Tags
RHHBY
BMY
why it's moving
From
Benzinga
Goldman Sachs Shifts Stance On Novartis, Cites Lack Of Near-Term Catalysts
September 05, 2024
Tickers
NEWS
NVO
NVS
Tags
Stories That Matter
Benzinga
Movers
From
Benzinga
S&P Global To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday
September 05, 2024
Tickers
AI
CE
CHPT
CNM
Tags
Analyst Ratings
analyst forecasts
CE
From
Benzinga
Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
September 03, 2024
Tickers
AMGN
AZN
BMY
JNJ
Tags
Government
Briefs
Biotech
From
Benzinga
Novartis' Cholesterol-Lowering Drug Shows Encouraging Outcome In Late-Stage Study
August 28, 2024
Tickers
NEWS
NVS
Tags
General
Benzinga
Stories That Matter
From
Benzinga
Siemens Healthineers To Buy Novartis Diagnostics To Bolster Cancer Scan Business In $220M Deal
August 26, 2024
Tickers
NEWS
NVS
Tags
Briefs
Biotech
Benzinga
From
Benzinga
2 Unstoppable Healthcare Stocks to Buy Right Now With Less Than $200
August 18, 2024
Tickers
DXCM
NVS
Tags
DXCM
NVS
Recent Press Releases
From
Motley Fool
Judge Rules Against Novartis' Effort To Halt Generic Launch Of Its Top-Selling Heart Disease Drug
August 13, 2024
Tickers
NEWS
NVS
Tags
Briefs
Benzinga
Stories That Matter
From
Benzinga
FDA Approves Expanded Use Of Novartis' Rare Disease Drug Fabhalta For Kidney Disease
August 08, 2024
Tickers
NEWS
NVS
Tags
Benzinga
Stories That Matter
Biotech
From
Benzinga
Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs
August 06, 2024
Tickers
NEWS
NVS
RARE
TMO
Tags
Top Stories
AI Generated
Health Care
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.